On 2025-05-08, Revelation Biosciences, Inc. (REVB) announced earnings per share of $-6.33 for the fiscal quarter ending 2025-03-31, beating the average analyst estimate of $-20.64.
The next expected annoucement date for quarterly earnings is 2025-08-08, with an average estimated earnings per share of $-4.46 for the fiscal quarter ending 2025-06-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-05-08 | 2025-03-31 | $-20.64 | $-6.33 |
| 2025-03-06 | 2024-12-31 | $-9.60 | $-14.94 |
| 2024-11-08 | 2024-09-30 | $-136.33 | $-40.32 |
| 2024-08-09 | 2024-06-30 | $-86.89 | $-73.93 |
| 2024-05-10 | 2024-03-31 | $-258.75 | $-118.09 |
| 2024-03-22 | 2023-12-31 | $-525.17 | $-399.88 |
| 2023-11-09 | 2023-09-30 | $-432.48 | $-591.05 |
| 2023-08-11 | 2023-06-30 | $-475.72 | $-360.40 |
| 2023-05-22 | 2023-03-31 | $-937.03 | $-735.21 |
| 2023-03-30 | 2022-12-31 | $-2522.77 | $-2551.61 |
| 2022-11-10 | 2022-09-30 | $-4536.46 | $-3024.31 |
| 2022-08-15 | 2022-06-30 | $-7056.71 | $-6048.61 |
| 2022-05-16 | 2022-03-31 | $-7056.71 | $-23690.39 |